NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Centers for Disease Control and Prevention (US); National Center for Chronic Disease Prevention and Health Promotion (US); Office on Smoking and Health (US). How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General. Atlanta (GA): Centers for Disease Control and Prevention (US); 2010.

How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General.
Show detailsTable 5.1IARC evaluations of carcinogens in mainstream cigarette smoke
IARC evaluations of evidence of carcinogenicity in humans | |||||
---|---|---|---|---|---|
Carcinogena | Quantity (per cigarette) | In animals | In humans | IARC groupb | IARC Monographc (volume, year) |
Polycyclic aromatic hydrocarbons | |||||
Benz[a]anthracene | 20–70 ng | Sufficient | 2A | 32, 1983; S7, 1987 | |
Benzo[b]fluoranthene | 4–22 ng | Sufficient | 2B | 32, 1983; S7, 1987 | |
Benzo[j]fluoranthene | 6–21 ng | Sufficient | 2B | 32, 1983; S7, 1987 | |
Benzo[k]fluoranthene | 6–12 ng | Sufficient | 2B | 32, 1983; S7, 1987 | |
Benzo[a]pyrene | 8.5–17.6 ng | Sufficient | Limited | 1 | 32, 1983; S7, 1987; 92, in press |
Dibenz[a,h]anthracene | 4 ng | Sufficient | 2A | 32, 1983; S7, 1987 | |
Dibenzo[a,i]pyrene | 1.7–3.2 ng | Sufficient | 2B | 32, 1983; S7, 1987 | |
Dibenzo[a,e]pyrene | Present | Sufficient | 2B | 32, 1983; S7, 1987 | |
Indeno[1,2,3-cd]pyrene | 4–20 ng | Sufficient | 2B | 32, 1983; S7, 1987 | |
5-methylchrysene | ND–0.6 ng | Sufficient | 2B | 32, 1983; S7, 1987 | |
Heterocyclic compounds | |||||
Furan | 20–40 μg | Sufficient | 2B | 63, 1995a | |
Dibenz[a,h]acridine | ND–0.1 ng | Sufficient | 2B | 32, 1983; S7, 1987 | |
Dibenz[a,j]acridine | ND–10 ng | Sufficient | 2B | 32, 1983; S7, 1987 | |
Dibenzo[c,g]carbazole | ND–0.7 ng | Sufficient | 2B | 32, 1983; S7, 1987 | |
Benzo[b]furan | Present | Sufficient | 2B | 63, 1995a | |
N-nitrosamines | |||||
N-nitrosodimethylamine | 0.1–180 ng | Sufficient | 2A | 17, 1978; S7, 1987 | |
N-nitrosoethylmethylamine | ND–13 ng | Sufficient | 2B | 17, 1978; S7, 1987 | |
N-nitrosodiethylamine | ND–25 ng | Sufficient | 2A | 17, 1978; S7, 1987 | |
N-nitrosopyrrolidine | 1.5–110 ng | Sufficient | 2B | 17, 1978; S7, 1987 | |
N-nitrosopiperidine | ND–9 ng | Sufficient | 2B | 17, 1978; S7, 1987 | |
N-nitrosodiethanolamine | ND–36 ng | Sufficient | 2B | 17, 1978; 77, 2000 | |
N’-nitrosonornicotine | 154–196 ng | Sufficient | Limited | 1 | 37, 1985; S7, 1987; 89, in press |
4-(methylnitrosamino)-1-(3-pyridyl) 1-butanone | 110–133 ng | Sufficient | Limited | 1 | 37, 1985; S7, 1987; 89, in press |
Aromatic amines | |||||
2-toluidine | 30–200 ng | Sufficient | Limited | 2A | S7, 1987; 77, 2000 |
2,6-dimethylaniline | 4–50 ng | Sufficient | 2B | 57, 1993 | |
2-naphthylamine | 1–22 ng | Sufficient | Sufficient | 1 | 4, 1974; S7, 1987 |
4-aminobiphenyl | 2–5 ng | Sufficient | Sufficient | 1 | 1, 1972; S7, 1987 |
Heterocyclic aromatic amines | |||||
2-amino-9H-pyrido[2,3-b]indole | 25–260 ng | Sufficient | 2B | 40, 1986; S7, 1987 | |
2-amino-3-methyl-9H-pyrido[2,3-b]indole | 2–37 ng | Sufficient | 2B | 40, 1986; S7, 1987 | |
2-amino-3-methylimidazo[4,5-f]quinoline | 0.3 ng | Sufficient | 2A | S7, 1987; 56, 1993 | |
3-amino-1,4-dimethyl-5H-pyrido [4,3-b]indole | 0.3–0.5 ng | Sufficient | 2B | 31, 1983; S7, 1987 | |
3-amino-1-methyl-5H-pyrido[4,3-b]indole | 0.8–1.1 ng | Sufficient | 2B | 31, 1983; S7, 1987 | |
2-amino-6-methylpyrido[1,2-a:3′, 2′-d]imidazole | 0.37–0.89 ng | Sufficient | 2B | 40, 1986; S7, 1987 | |
2-aminodipyrido[1,2-a:3′,2′-d]imidazole | 0.25–0.88 ng | Sufficient | 2B | 40, 1986; S7, 1987 | |
2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine | 11–23 ng | Sufficient | 2B | 56, 1993 | |
Aldehydes | |||||
Formaldehyde | 10.3–25 μg | Sufficient | Sufficient | 1 | S7, 1987; 62, 1995b |
Acetaldehyde | 770–864 μg | Sufficient | 2B | S7, 1987; 71, 1999 | |
Phenolic compounds | |||||
Catechol | 59–81 μg | Sufficient | 2B | S7, 1987; 71, 1999 | |
Caffeic acid | <3 μg | Sufficient | 2B | 56, 1993 | |
Volatile hydrocarbons | |||||
1,3-butadiene | 20–40 μg | Sufficient | Limited | 2A | S7, 1987; 71, 1999 |
Isoprene | 450–1,000 μg | Sufficient | 2B | 60, 1994; 71, 1999 | |
Benzene | 12–50 μg | Sufficient | Sufficient | 1 | 29, 1982; S7, 1987 |
Nitrohydrocarbons | |||||
Nitromethane | 0.5–0.6 μg | Sufficient | 2B | 77, 2000 | |
2-nitropropane | 0.7–1.2 ng | Sufficient | 2B | S7, 1987; 71, 1999 | |
Nitrobenzene | 25 μg | Sufficient | 2B | 65, 1996 | |
Miscellaneous organic compounds | |||||
Acetamide | 38–56 μg | Sufficient | 2B | S7, 1987; 71, 1999 | |
Acrylamide | Present | Sufficient | 2A | S7, 1987; 60, 1994 | |
Acrylonitrile | 3–15 μg | Sufficient | 2B | S7, 1987; 71, 1999 | |
Vinyl chloride | 11–15 ng | Sufficient | Sufficient | 1 | 19, 1979; S7, 1987 |
1,1-dimethylhydrazine | Present | Sufficient | 2B | 4, 1974; 71, 1999 | |
Ethylene oxide | 7 μg | Sufficient | Limited | 1 | 60, 1994; S7, 1987 |
Propylene oxide | 0–100 ng | Sufficient | 2B | 60, 1994; S7, 1987 | |
Urethane | 20–38 ng | Sufficient | 2B | 7, 1974; S7, 1987 | |
Metals and inorganic compounds | |||||
Arsenic | 40–120 ng | Sufficient | Sufficient | 1 | 84, 2004 |
Beryllium | 0.5 ng | Sufficient | Sufficient | 1 | S7, 1987; 58, 1993 |
Nickel | ND–600 ng | Sufficient | Sufficient | 1 | S7, 1987; 49, 1990 |
Chromium (hexavalent) | 4–70 ng | Sufficient | Sufficient | 1 | S7, 1987; 49, 1990 |
Cadmium | 41–62 ng | Sufficient | Sufficient | 1 | S7, 1987; 58, 1993 |
Cobalt | 0.13–0.20 ng | Sufficient | 2B | 52, 1991 | |
Lead (inorganic) | 34–85 ng | Sufficient | Limited | 2A | 23, 1980; S7, 1987; 87, in press |
Hydrazine | 24–43 ng | Sufficient | 2B | S7, 1987; 71, 1999 | |
Radioisotope polonium-210 | 0.03–1.0 picocurie | Sufficient | 1 | 78, 2001 |
Source: Adapted from Hoffmann et al. 2001 and International Agency for Research on Cancer 2004 with permission from American Chemical Society, © 2001 and International Agency for Research on Cancer, © 2004.
- a
Virtually all these compounds are known carcinogens in experimental animals, and IARC found sufficient evidence for carcinogenicity in animals for all the compounds.
- b
Using data on cancer in humans and, in some cases, other data, IARC established classifications for compounds as group 1 (carcinogenic to humans), group 2A (probably carcinogenic to humans), and group 2B (possibly carcinogenic to humans).
- c
If more than two IARC evaluations were performed, only the two most recent monographs are listed.
- Table 5.1, IARC evaluations of carcinogens in mainstream cigarette smoke - How T...Table 5.1, IARC evaluations of carcinogens in mainstream cigarette smoke - How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease
Your browsing activity is empty.
Activity recording is turned off.
See more...